Microgels and microtissues for use in tissue engineering

Patent metadata

Field	Value
Publication number	US-10260039-B2
Application number	US-201214116901-A
Country	US
Kind code	B2
Filing date	May 11, 2012
Priority date	May 11, 2011
Publication date	Apr 16, 2019
Grant date	Apr 16, 2019

Abstract

The present invention features microgels and microtissues for use in tissue engineering. Featured is a microencapsulation device for making microgels and/or microtissues via an emulsion technology. Also featured are methods of making higher ordered structures that mimic in vivo tissue structures. Methods of us are also featured.

First claim

We claim:

1. A method of making a plurality of microtissues, comprising injecting into a channel of a microfluidic device a first input stream comprising a solution of cells and a second input stream comprising a polymerizable hydrogel solution to form a combined aqueous stream;
emulsifying the combined aqueous stream with an oil stream in a first region of the channel of the microfluidic device, to produce droplets comprising the cells in the polymerizable hydrogel;
mixing said droplets to disperse the cells in the polymerizable hydrogel in a second region of the channel comprising a corrugated section in the microfluidic device;
polymerizing the droplets comprising the cells dispersed in the polymerizable hydrogel to form the microtissues; and
collecting the microtissues from an outlet of the device,
such that the plurality of microtissues is made.

2. The method of claim 1 , wherein the hydrogel material is agarose, fibrin, or polyethylene hydrogel.

3. A method of making a plurality of microtissues, comprising injecting into a channel of a microfluidic device a solution comprising pre-stabilized, micropatterned cell clusters and a polymerizable hydrogel solution, wherein the cell clusters comprise parenchymal cells and supporting nonparenchymal cells;
emulsifying the solution of cell clusters and polymerizable hydrogel with an oil stream in a channel of the microfluidic device, to produce droplets comprising the cell clusters in the polymerizable hydrogel,
polymerizing the droplets comprising the cell clusters dispersed in the polymerizable hydrogel to form the microtissues, wherein polymerizing occurs during transport of the droplets, wherein transport occurs continuously; and
collecting the microtissues from an outlet of the device,
such that the plurality of microtissues is made.

4. The method of claim 3 , wherein the cell clusters comprise primary hepatocytes and stromal cells.

5. The method of claim 3 , wherein the cell clusters comprise hepatocytes selected from the group consisting of progenitor-derived hepatocytes, ES-derived hepatocytes, and induced pluripotent stem cell-derived (iPS-derived) hepatocytes, and stromal cells.

6. The method of claim 3 , wherein the cell clusters comprise cancer cells and stromal cells.

7. The method of claim 1 or 3 , wherein the polymerizable hydrogel is a photopolymerizable hydrogel.

8. The method of any one of claims 1 - 4 , wherein the hydrogel is functionalized with one or more affinity biomolecules facilitating higher ordered assembly of the said microtissues.

9. The method of claim 8 , wherein the biomolecule is streptavidin, or a cell adhesive peptide.

10. The method of claim 3 , wherein the droplets or microtissues are about 50 to about 250 μM in diameter.

11. The method of claim 1 or 3 , wherein the droplets or microtissues are about 20 to about 150 μM in diameter.

12. The method of claim 1 or 3 , wherein the droplets comprise about 1 to about 50 cells.

13. The method of claim 1 or 3 , wherein each microtissue comprises about 2 to about 20 cells or wherein each microtissue comprises about 5 to about 10 cells.

14. The method of claim 4 , wherein the stromal cells are fibroblasts.

15. The method of claim 5 , wherein the stromal cells are fibroblasts.

16. The method of claim 6 , wherein the stromal cells are fibroblasts.

17. The method of claim 7 , wherein the photopolymerziable hydrogel is polyethylene glycol (PEG) hydrogel.

18. The method of claim 9 , wherein the biomolecule is a RGDS peptide.

Assignees

• Bhatia Sangeeta N
• Li Cheri Y
• Massachusetts Inst Technology

Inventors

• Bhatia Sangeeta N
• Li Cheri Y

Classifications

• C12N5/0012 Primary

  Cell encapsulation · CPC title

• C12N5/0062

  General methods for three-dimensional culture · CPC title

• C12N2533/30

  Synthetic polymers · CPC title

• C12N5/0671

  Three-dimensional culture, tissue culture or organ culture; Encapsulated cells · CPC title

• C12N2531/00

  Microcarriers · CPC title